A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas

Soragni, Alice, Janzen, Deanna M., Johnson, Lisa M., Lindgren, Anne G., Thai-Quynh Nguyen, Anh, Tiourin, Ekaterina, Soriaga, Angela B., Lu, Jing +5 more·2016·Cancer Cell

DOI 10.1016/j.ccell.2015.12.002

Cited by (343)

Items 201–300 of 343

The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations
Anna Hertel, Zuzana Štorchová · 2025 · Biomolecules
Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53–R175H mutant aggregation
Jiangtao Lei, Mengqiang Cai, Yun Shen, Dongdong Lin, Xiaohua Deng · 2021 · Physical Chemistry Chemical Physics
NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner
Bi‐He Cai, Zhi-Yu Bai, Ching‐Feng Lien, Si-Jie Yu, Rui-Yu Lu, Ming-Han Wu, Wei-Chen Wu, Chia‐Chi Chen, Yi‐Chiang Hsu · 2022 · Biomolecules
The Evolution of Functional Amyloids and Their Impact on Host–Microbe Interactions
Divya Kolli, Saroj K. Rout, Roland Riek, Matthew R. Chapman · 2025 · Advanced Science
Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer
Fangfang Xu, Tingwei Liu, Zhuonan Zhou, Chang Zou, Shaohua Xu · 2021 · Frontiers in Immunology
A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer
Jessica J. Miller, Kalvin Kwan, Christian Gaiddon, Tim Storr · 2022 · JBIC Journal of Biological Inorganic Chemistry
The chameleonic behavior of p53 in health and disease: the transition from a client to an aberrant condensate scaffold in cancer
Mayra A. Marques, Guilherme A. P. de Oliveira, Jerson Lima Silva · 2022 · Essays in Biochemistry
Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules
Lauryn Grcic, Grace Leech, Kalvin Kwan, Tim Storr · 2024 · Chemical Communications
Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma
Jingzhi Li, Ming Guo, Lin Chen, Zhuchu Chen, Ying Fu, Yongheng Chen · 2024 · Cell Death and Disease
Mutations, protein homeostasis, and epigenetic control of genome integrity
Jinglin Lucy Xie, Daniel F. Jarosz · 2018 · DNA repair
How I Treat TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes
Michael L. Loschi, Pierre Fenaux, Thomas Cluzeau · 2022 · Cancers
Effect of Mutation on an Aggregation-Prone Segment of p53: From Monomer to Dimer to Multimer
Atanu Das, Dmitrii E. Makarov · 2016 · The Journal of Physical Chemistry B
How Tumor Virology Evolved into Cancer Biology and Transformed Oncology
HAROLD E. VARMUS · 2016 · Annual Review of Cancer Biology
Liquid–Liquid Phase Separation in Major Hallmarks of Cancer
Chen‐chen Xie, Ting Wang, X P Liu, Yan Wang, Qin Dang, Tian Ding, Jia‐qi Xu, Xianjun Yu, Hai Lan Lin, Xiaowu Xu et al. · 2025 · Cell Proliferation
In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors
Sekkarin Ploypetch, Sittiruk Roytrakul, Narumon Phaonakrop, Suthathip Kittisenachai, Kantinan Leetanasaksakul, Sirinun Pisamai, Chanin Kalpravidh, Anudep Rungsipipat, Gunnaporn Suriyaphol · 2020 · BMC Veterinary Research
Phase Separation and Prion‐Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer Treatment
Jerson Lima Silva, Guilherme Caldas de Andrade, Elaine C. Petronilho, Gileno dos S. de Sousa, Michelle F. Mota, Julia Quarti, Francisca Hildemagna Guedes-da-Silva, Giulia D. S. Ferretti, Luciana Pereira Rangel, Tuane C. R. G. Vieira et al. · 2025 · Journal of Neurochemistry
Determination of Eupatilin in Folium artemisiae Argyi and Its Inhibitory Effect on Hepatoma Cells
Guoan Xiang, Rui Liu, Jin Hua Zhao, Ke He, Xiaodong Zhang, Liang Chang · 2018 · Pharmacognosy Magazine
Fragment-Based Ab Initio Phasing of Peptidic Nanocrystals by MicroED
Logan S. Richards, Maria D. Flores, Claudia Millán, Calina A. Glynn, Chih-Te Zee, Michael R. Sawaya, Marcus Gallagher-Jones, Rafael J. Borges, Isabel Usón, José A. Rodríguez · 2023 · ACS Bio & Med Chem Au
Restoration of conformation of mutant p53
J.A. Green, M. Von Euler, Lars Abrahmsén · 2018 · Annals of Oncology
Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer
Katherine E. Redd Bowman, Ji Hoon Kim, Carol S. Lim · 2019 · Journal of Ovarian Research
Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancer
Xingxing Li, Jingyun Li, Bin Zhang, Yuqing Gu, Qian Li, Guangliang Gu, Jiageng Xiong, Yanan Li, Xiaojun Yang, Zhuyin Qian · 2020 · The International Journal of Biochemistry & Cell Biology
p53, A Victim of the Prion Fashion
Olivier Billant, Gaëlle Friocourt, Pierre Roux, Cécile Voisset · 2021 · Cancers
A Peptide Strategy for Inhibiting Different Protein Aggregation Pathways
Tommaso Garfagnini, Luca Ferrari, Margreet B. Koopman, Françoise A. Dekker, Sem Halters, Eline C van Kappel, Guy Mayer, Shachar Bressler, Madelon M. Maurice, Stefan Rüdiger et al. · 2024 · Chemistry - A European Journal
Phase separation in DNA damage response: New insights into cancer development and therapy
Lingwei Li, Litong Yao, Mozhi Wang, Xiang Zhou, Yingying Xu · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers
Daxing Xu, Wei Qian, Zhenkun Yang, Zhenghao Zhang, Ping Sun, Quan Wan, Ying Yin, Yaling Hu, Lingli Gong, Bo Zhang et al. · 2023 · iScience
Perspectives on drug discovery strategies based on IDPs
Gustavo Fuertes, Laura Nevola, Santi Esteban-Martín · 2019 · Elsevier eBooks
Disulfide linked hetero dimeric peptide arrays for screening functional peptides inside cells
Ikko Kozaki, Kazunori Shimizu, Hiroyuki Honda · 2019 · Journal of Bioscience and Bioengineering
Cellular Functions of Deubiquitinating Enzymes in Ovarian Adenocarcinoma
Yosuk Min, Hong‐Beom Park, Kwang‐Hyun Baek, Sohyun Hwang · 2023 · Genes
Elucidating the Mechanisms of R248Q Mutation-Enhanced p53 Aggregation and Its Inhibition by Resveratrol
Qian Liu, Le Li, Yawei Yu, Guanghong Wei · 2023 · The Journal of Physical Chemistry B
Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX36-58
Xusu Wang, Guangquan Liu, Na Sheng, Mi Zhang, Xinxing Pan, Siyu Liu, Ke Huang, Yu Cong, Qing Xu, Xuemei Jia et al. · 2020 · Annals of Translational Medicine
Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy
Menglei Zhang, Yuanyuan Gu, Fang Shen, Yingxin Gong, Zheng Gu, Keqin Hua, Guannan Zhou, Jingxin Ding · 2025 · Journal of Ovarian Research
Detection of p53 aggregates in plasma of glioma patients
Yunzhao Wu, Jeff Y. L. Lam, Matthaios Pitoulias, Dorothea Böken, Zi-Wei Zhang, Renuka Chintapalli, Emre Fertan, Zengjie Xia, John S. H. Danial, Gemma Tsang-Pells et al. · 2025 · Communications Medicine
Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma
Kazuchika Nishitsuji, Remi Mito, Midori Ikezaki, Hiromu Yano, Yukio Fujiwara, Eri Matsubara, Taro Nishikawa, Yoshito Ihara, Kenji Uchimura, Naoyuki Iwahashi et al. · 2024 · Cancer Science
Understanding the mechanism of amylin aggregation: From identifying crucial segments to tracing dominant sequential events to modeling potential aggregation suppressors
Ritama Ghosh, Shreyan Ghosh, Atanu Das · 2022 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Tat-hspb1 Suppresses Clear Cell Renal Cell Carcinoma (ccRCC) Growth via Lysosomal Membrane Permeabilization
Lin Zhang, Guang‐Zhi Jin, Dong Li · 2022 · Cancers
Recent advances in the modulation of amyloid protein aggregation using the supramolecular host-guest approaches
Debabrata Maity · 2023 · Biophysical Chemistry
Suppressing cancer by damaging cancer cell DNA using LED irradiation
Yu-Jin Kim, Jihun Song, Donghyun Lee, Soong Ho Um, Suk Ho Bhang · 2023 · Journal of Photochemistry and Photobiology B Biology
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
Phong Lu, Erica R. Vander Mause, Katherine E. Redd Bowman, Sarah M. Brown, Lisa Ahne, Carol S. Lim · 2019 · Journal of Ovarian Research
Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies
Emily Palumbo, Bi Zhao, Bin Xue, Vladimir Nikolaevich Uversky, Vrushank Davé · 2019 · Journal of Biomolecular Structure and Dynamics
Promising Proteolysis-Targeting Chimera for Mutant p53-R175H
Xinzhe Zhuang, Yidan Guo, Xiaozi Sun, Jie Chen, Songbo Xie, Fengtang Yang, Jingrui Li · 2024 · ACS Omega
USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
Shaoxuan Cheng, Zhiyuan Qiu, Ziyi Zhang, Yuxuan Li, Yue Zhu, Yuxin Zhou, Yinghui Yang, Yaowen Zhang, Dian Yang, Yingqiu Zhang et al. · 2025 · Cell Communication and Signaling
Fluorescent Biosensor for Detection of the R248Q Aggregation‐Prone Mutant of p53
Morgan Pellerano, Delphine Naud‐Martin, Florence Mahuteau‐Betzer, Marie Morille, May Catherine Morris · 2018 · ChemBioChem
Relevance of Amorphous and Amyloid-Like Aggregates of the p53 Core Domain to Loss of its DNA-Binding Activity
Emi Hibino, Takeshi Tenno, Hidekazu Hiroaki · 2022 · Frontiers in Molecular Biosciences
Mutant p53 rescued by aggregation inhibitor
Alexandra Flemming · 2016 · Nature Reviews Drug Discovery
Mass spectrometry-based peptidome profiling of human serous ovarian cancer tissues
Juan Xu, Xusu Wang, Pengfei Xu, Siyu Liu, Fang Teng, Xiaoguang Liu, Qiaoying Zhu, Xiangdong Hua, Zhen Hui Gong, Xuemei Jia · 2018 · The International Journal of Biochemistry & Cell Biology
Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth
Lulu Guan, Yalan Yang, Yao Lu, Yu Chen, Xi Luo, Dao Xin, Xiangrui Meng, Zhengzheng Shan, Guozhong Jiang, Feng Wang · 2023 · Frontiers in Pharmacology
Silence of linc00023 inhibits pyroptosis and promotes cell proliferation via regulating p53
Anyi Zhu, Cheng Cheng, Shuangquan Lin, Zhengdong Hong, Zimin Shi, Huanhuan Deng, Gan Zhang · 2023 · Gene
Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly
Mona Kalmouni, Yujeong Oh, Waël Alata, Mazin M. Magzoub · 2024 · Pharmaceutics
A new biology of cell penetrating peptides
John Howl, Sarah Jones · 2020 · Peptide Science
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide
Gu Xiao, George K. Annor, Kimberly Fung, Outi M. Keinänen, Brian M. Zeglis, Jill Bargonetti · 2020 · Molecular Pharmaceutics
Scan-Find-Scan-Model: Discrete Site-Targeted Suppressor Design Strategy for Amyloid-β
Hasathi Bhagavatula, Archishman Sarkar, Binit Santra, Atanu Das · 2022 · ACS Chemical Neuroscience
A comparison of four technologies for detecting p53 aggregates in ovarian cancer
Nicole Heinzl, Katarzyna Kozieł, Elisabeth Maritschnegg, Astrid Berger, Elisabeth Judith Pechriggl, Heidi Fiegl, Alain Gustave Zeimet, Christian Marth, Robert Zeillinger, Nicole Concin · 2022 · Frontiers in Oncology
Identification and characterization of R2TP in the development of oral squamous cell carcinoma
Tetsuo Kiguchi, Yoshito Kakihara, Manabu Yamazaki, Kouji Katsura, Kenji Izumi, Jun‐ichi Tanuma, Takashi Saku, Ritsuo Takagi, Makio Saeki · 2021 · Biochemical and Biophysical Research Communications
Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants
Lu Yang, Yun Li, Arup Bhattacharya, Yuesheng Zhang · 2021 · Communications Biology
Cellular metabolic pathways of aging in dogs: could p53 and SIRT1 be at play?
Ana Gabriela Jiménez, Kailey D. Paul, Mitchel Benson, Sahil Lalwani, William Cipolli · 2023 · GeroScience
Oncogenic R248W mutation induced conformational perturbation of the p53 core domain and the structural protection by proteomimetic amyloid inhibitor ADH-6
Qian Liu, Yawei Yu, Guanghong Wei · 2024 · Physical Chemistry Chemical Physics
Identification of CNOT1-CCR4-NOT as a suppressor of 53BP1-p53-p21 signaling
Antonio Galarreta, Virginia Pasti, Julia Vornberger, Ralph Imhof, Mariano Oppikofer, Matthias Altmeyer · 2025 · Cell Reports
Small molecules modulate the biomolecular condensates and liquid‒liquid phase separation
Kaiyue Lian, Fajun Nan · 2026 · Acta Pharmaceutica Sinica B
Conformational inhibitors of protein aggregation
María del Carmen Fernández‐Ramírez, Shumaila Afrin, Lorena Saelices · 2023 · Current Opinion in Structural Biology
Liquid–liquid phase separation in hepatocellular carcinoma
Jianguo Xu, Wangwang Liu, Yihan Yao, Tuomas P. J. Knowles, Zhigang Zhang, Yanli Zhang · 2024 · Frontiers in Cell and Developmental Biology
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium
Nicole Heinzl, Elisabeth Maritschnegg, Katarzyna Kozieł, Christine Wallisch, Georg Heinze, Wei‐Lei Yang, Robert C. Bast, Jalid Sehouli, Elena Ioana Braicu, Ignace B. Vergote et al. · 2023 · Oncogene
Mesoscopic Liquid Clusters Represent a Distinct Condensate of Mutant p53
David S. Yang, Arash Saeedi, Aram Davtyan, Mohsen Fathi, Mohammad S. Safari, Alena Klindziuk, Michelle Craig Barton, Navin Varadarajan, Anatoly B. Kolomeisky, Peter G. Vekilov · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Designed inhibitors to reduce amyloid virulence and cytotoxicity and combat neurodegenerative and infectious diseases
Rinat Yona Indig, Meytal Landau · 2023 · Current Opinion in Chemical Biology
Biomarkers in glioblastoma and degenerative CNS diseases: defining new advances in clinical usefulness and therapeutic molecular target
Fan Bu, Jifa Zhong, Ruiqian Guan · 2025 · Frontiers in Molecular Biosciences
Unfolding the roles of resveratrol in p53 regulation
Rafaela Muniz de Queiroz, Carol L. Prives · 2018 · Oncotarget
Potential enhancement of post-stroke angiogenic response by targeting the oligomeric aggregation of p53 protein
Hoi Hei Tam, Dongxing Zhu, Samuel Sze King Ho, Heng Wai Vong, Vincent Kam Wai Wong, Simon Wing-Fai Mok, Io Nam Wong · 2023 · Frontiers in Cellular Neuroscience
Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions
Yasaman Naeimzadeh, Amir Tajbakhsh, Jafar Fallahi · 2024 · Heliyon
Intestinal Epithelial Lgr5 + Stem Cell Niche and Organoids
Nobuo Sasaki, Toshiro Sato, Hans C. Clevers · 2017 · Elsevier eBooks
A systematic review of emerging technologies to enhance the treatment of ovarian cancer
Samaneh Sepahi, Lily Kiaei, Mahmoud Kiaei, Adel Ghorani‐Azam · 2023 · Pharmaceutical Development and Technology
Structural And Computational Perspectives of Selectively Targeting Mutant Proteins
Matt Coban, Sarah Fraga, Thomas R. Caulfield · 2020 · Current Drug Discovery Technologies
Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments
Gregory-Neal W Gomes, Zachary A. Levine · 2021 · The Journal of Physical Chemistry B
Unraveling the unique amyloid-like aggregation behavior of the tumor suppressor p53 mutants in human cancers
Nisha Manav, Pratibha Sharma, Sankat Mochan, Lakshay Malhotra · 2025 · International Journal of Biological Macromolecules
Phylogenomics to structure: evolutionary and clinical signals in the TP53 DNA-binding core through LOOCV-validated ensemble learning
Syed Raza Abbas, Zeeshan Abbas, Arifa Zahir, Mobeen Ur Rehman, Seung Won Lee · 2026 · Briefings in Bioinformatics
Phase Separation: A New Dimension to Understanding Tumor Biology and Therapy
Xingwen Wang, Minqiao Lu, Yi Zhang, Jiangwen Ma, Ying Chuan Hu · 2025 · MedComm – Oncology
Analysis of p53 expression in partial hydatidiform mole and hydropic abortion
Parvin Kheradmand, Maede Goudarzi, Mina Tavakoli · 2017 · Frontiers in Biology
Identification of DDX5 as a Potential Therapeutic Target of Osteosarcoma Using Thiazolone Probes
Donghui Sun, Kang Li, Xuwen Chen, Jian Xue, Xin Wu, Jiemin Wong, Qinghua Wei, Shunying Liu · 2024 · ACS Chemical Biology
Methods to Screen Compounds Against Mutant p53 Misfolding and Aggregation for Cancer Therapeutics
Giulia D. S. Ferretti, Danielly C. Ferraz da Costa, Jerson Lima Silva, Luciana Pereira Rangel · 2018 · Methods in molecular biology
TSPYL5-driven G3BP1 nuclear membrane translocation facilitates p53 cytoplasm sequestration via accelerating RanBP2-mediated p53 sumoylation and nuclear export in neuroblastoma
Zhaokun Wang, Yunqiang Liu, Yangwei Zhang, Jiaying Shi, Shengyu Xie, Ming Yi, Xinyue Zhang, Dachang Tao, Yuan Yang · 2025 · Cell Death and Disease
Evaluation of dual-function molecules containing both Zn-Ionophore and aggregation inhibition moieties for mutant p53 protein reactivation
Kalvin Kwan, Ashkan Saffari, Lauryn Grcic, Alfredo L. Acosta, Grace Leech, Benjamin Ma, Omar Castro-Sandoval, Christophe Orvain, Georg Mellitzer, Christian Gaiddon et al. · 2025 · Journal of Inorganic Biochemistry
Magnetic graphene-based ferrite nanoparticles: synthesis, characterization, and anti-proliferative activity against some human cancer cells ( in vitro study)
Abdelsattar O.E. Abdelhalim, Nasra F. Abdel Fattah, Mohamed Hussein, Mangoud Mangoud, Samah Aly Loutfy · 2026 · RSC Advances
Artificial sweetener acesulfame induces oxidative stress, neurotoxicity, and glycolipid metabolic disruption in zebrafish (Danio rerio)
Xue Liu, Qian Wang, Huijuan Lv, Baoyan Mu, Yali Zhou, Xianxu Li, Min Ding, Nan Jiang, Jun Wang · 2026 · Environmental Pollution
Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation
Suzana da Silva Benedito, Paula Sabbo Bernardo, Jean‐Edouard Martin, Caroline Marty, Isabelle Plo, Iléana Antony‐Debré, Bárbara da Costa Reis Monte-Mór · 2026 · HemaSphere
Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy.
Xue-Ping Wang, Jinsui Li, Xingping Wu, Can Pan, M. Luo, Kai Fu, Sijia Li, Shuangli Zhu, Yuelu Lan, Ying-Fang Fan et al. · 2026 · Drug resistance updates
Precision peptide disruptors: The next generation of targeted therapeutics in oncology
Bria O'Gorman, Sean F Cooke, Connor M. Blair · 2025 · Cellular Signalling
Targeting phase separation: a promising treatment option for hepatocellular carcinoma
Ziling Zhou, Sikan Jin, Xiaoming Li, Dan Zhang, Shengxi Zhang, He Zhou, Cai Ji, Tao Song, Xianyao Wang, Qinghong Kong et al. · 2025 · Cell Communication and Signaling
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Vy Phan-Lai · 2016 · Biomedical Research and Therapy
Targeting TP53 to augment therapeutic response in head and neck cancer
Abdullah A. Osman, Antje Lindemann, Li Wang, Steven Jay Frank, Jeffrey N. Myers · 2020 · Elsevier eBooks
Chemical and biological characterization of lipid profile from Hydroclathrus clathraus
Eman Ahmed Ibrahim, Mahmoud Taha Abo-Elfadl, Hanaa H. Abd El Baky, Soha Ahmed Murad · 2021 · Egyptian Journal of Chemistry
Exploring Mechanisms of Inhibition of Amyloid Seeding of Transthyretin
Lorena Saelices, Kevin Chung, Ji Hun Lee, Teresa Coelho, Johan Bijzet, Merrill Douglas Benson, David S Eisenberg · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
Induction of intracellular wild-type p53 amyloids leading to cellular transformation and tumor formation in mice
Ambuja Navalkar, Satyaprakash Pandey, Namrata Singh, Amit Kumar Dey, Sandhini Saha, Komal Patel, Bhabani Shankar Mohanty, Sachin Hanumantrao Jadhav, Pradip R. Chaudhari, Tushar Kanti Maiti et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
The guardian of the genome meets a viral master gene regulator at a biomolecular condensate
Silvia Susana Borkosky, Marisol Fassolari, Karen Campos-León, Andres Hugo Rossi, Mariano Salgueiro, Carla Antonela Pascuale, Ramón Peralta Martínez, Kevin Gaston, Gonzalo de Prat Gay · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Mutant p53 Misfolding and Aggregation Precedes Transformation into High-Grade Serous Ovarian Carcinoma
Sara Sartini, Lexi Omholt, Neda A. Moatamed, Alice Soragni · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation
Evelyne Naus, Marleen Derweduwe, Youlia Lampi, Annelies Claeys, Jarne Pauwels, Tobias Langenberg, Filip Claes, Jie Xu, Veerle Haemels, Zeynep Kalender Atak et al. · 2020 · Cells
Molecular Diagnostics of Cancer [Working Title]
Piccaluga, Pier Paolo · 2023 · IntechOpen eBooks
Advances in Aggrephagy: Mechanisms, Disease Implications, and Therapeutic Strategies
Haixia Zhuang, Xinyu Ma · 2025 · Journal of Cellular Physiology
Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib
Bongkyun Kang, Sun-Jae Lee, Ki Ho Seol, Yoon Young Jeong, Jung‐Hye Choi, Bo-Hyun Choi, Jung Min Ryu, Youn Seok Choi · 2025 · International Journal of Molecular Sciences
Experimental kinetic mechanism of P53 condensation-amyloid aggregation
Silvia Susana Borkosky, Ramon Peralta-Martinez, Alicia Armella-Sierra, Sebastián Esperante, Leonardo Lizárraga, Javier García‐Pardo, Salvador Ventura, Ignacio Enrique Sanchez, Gonzalo de Prat Gay · 2025 · Biophysical Journal
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer
Monika Raab, Khayal Gasimli, Balázs Győrffy, Samuel Peña‐Llopis, Sven Becker, Mourad Sanhaji, Klaus Strebhardt · 2025 · Cancers
Targeting p53 in Cancer: Functional States, Therapeutic Strategies, and Clinical Progress
Anais Saunders, Joshua Barkin, Anthony Nicholas Karnezis, Jeremy Chien · 2026 · Cancers
An Insight into Targeted Therapy for Ovarian Cancer
Abhishek Chatterjee, Vineet Kumar Mishra, Susmita Saha, Snehasikta Swarnakar · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects